Evolus to Hold Conference Call Following Jeuveau™ FDA Approval
February 04, 2019 06:00 ET
|
Evolus
NEWPORT BEACH, Calif., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), today announced that members of management will host a conference call today, February 4th, 2019, at 8:00 a.m....
Evolus Receives FDA Approval for Jeuveau™ prabotulinumtoxinA-xvfs for Injection
February 01, 2019 16:57 ET
|
Evolus
Jeuveau™ is the first aesthetic-only neurotoxin approved in the U.S. – launch planned Spring 2019 Global clinical program in 2,100 subjects, known as TRANSPARENCY, included two Phase III U.S. trials,...
Evolus Added to NASDAQ Biotechnology Index
December 19, 2018 08:01 ET
|
Evolus
IRVINE, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced that the company has been selected for addition to the...
Evolus Receives Conditional FDA Acceptance of Jeuveau™ Brand Name
November 19, 2018 05:30 ET
|
Evolus
IRVINE, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced the conditional acceptance from the U.S. Food and Drug...
Evolus Reports Third Quarter 2018 Financial Results
November 05, 2018 16:05 ET
|
Evolus
- Within 90 Days of FDA PDUFA Action Date for DWP-450 - - Granted Marketing Approval for DWP-450 by Health Canada - - Conference Call Today at 4:30PM ET - IRVINE, Calif., Nov. 05, 2018 (GLOBE...
Evolus to Participate in Two Upcoming Investor Conferences
November 01, 2018 08:01 ET
|
Evolus
IRVINE, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ:EOLS), a company dedicated to aesthetic medicine, announced today that members of management will be participating in two...
Evolus Expands Leadership Team with Appointments of Key Executives
October 22, 2018 16:01 ET
|
Evolus
Appoints Kurt Knab as Vice President, Sales Appoints Alejandro “Alex” Sabad as Vice President, Operations Appoints Amy Marinne Fox as Vice President, Human Resources IRVINE, Calif., Oct. 22,...
Evolus to Release Third Quarter 2018 Financial Results on Monday, November 5, 2018
October 18, 2018 08:01 ET
|
Evolus
IRVINE, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced that it will release 2018 third quarter financial results...
Evolus to Present at the Cantor Global Healthcare Conference
September 20, 2018 16:01 ET
|
Evolus
IRVINE, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ:EOLS), a company dedicated to aesthetic medicine, announced today that members of management will present at the Cantor Global...
Evolus Appoints Ashwin K. Agarwal as Vice President, Finance, Investor Relations and Treasury
September 05, 2018 08:01 ET
|
Evolus
IRVINE, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced the appointment of Ashwin K. Agarwal as Vice President,...